02005nam a2200421 a 4500003491529MiAaHDL20250726000000.0m d cr bn ---auaua000710s1996 dcua b f000 0 eng d(MiU)990034915290106381sdr-miu.990034915290106381(MiU)MIU01000000000000003491529-goog(OCoLC)34639204(MiU)Aleph003491529156480GAO (202) 512-6000 (Voice); (301) 258-4066 (Fax)GAOGAOEYMUtOrBLWe------GA 1.13:HEHS-96-71B-261605GAO/HEHS-96-71HV5823.5.E97U33United States.General Accounting Office.http://id.loc.gov/authorities/names/n80126064http://id.loc.gov/rwo/agents/n80126064European Union drug approval :overview of new European Medicines Evaluation Agency and approval process : report to the Chairman, Committee on Labor and Human Resources, U.S. Senate /United States General Accounting Office.Overview of new European Medicines Evaluation Agency and approval processWashington, D.C. :The Office ;Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) :The Office [distributor],[1996]21 p. :ill. ;28 cmtexttxtrdacontentunmediatednrdamediavolumencrdacarrier"B-261605"--P. 1."GAO/HEHS-96-71.""April 1996."Cover title.Includes bibliographical references.Mode of access: Internet.European federation.http://id.loc.gov/authorities/subjects/sh85045814DrugsEuropeTesting.DrugsLaw and legislationEurope.United States.Congress.Senate.Committee on Labor and Human Resources.http://id.loc.gov/authorities/names/n80063281http://id.loc.gov/rwo/agents/n8006328139015048861408Buhr B 150843500349152920241218065757.020250726000000.020260308165301.02026-03-09T08:57:26Z2024-10-03T17:30:02ZSDR-MIUmiuALMAprepare.pl-004-009BKsdr-miu.990034915290106381MiUSDRMIU003491529mdp.39015048861408MIU990034915290106381MIUMIU20260309googlemdp.390150488614081996pdbibUS fed doc